{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T09:51:31Z","timestamp":1763977891856},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/jhh.2015.56","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T09:21:37Z","timestamp":1433409697000},"page":"204-209","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial"],"prefix":"10.1038","volume":"30","author":[{"given":"T I","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"London","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G A","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T B","family":"Dr\u00fceke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Floege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C A","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K W","family":"Mahaffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Moe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P S","family":"Parfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D C","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Dehmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W G","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"issue":"7","key":"BFjhh201556_CR1","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","volume":"15","author":"AP Guerin","year":"2000","unstructured":"Guerin AP, London GM, Marchais SJ, Metivier F . Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15 (7): 1014\u20131021.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"BFjhh201556_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.HYP.0000159190.71253.c3","volume":"45","author":"B Pannier","year":"2005","unstructured":"Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM . Stiffness of capacitive and conduit arteries: Prognostic significance for end-stage renal disease patients. Hypertension 2005; 45 (4): 592\u2013596.","journal-title":"Hypertension"},{"issue":"5","key":"BFjhh201556_CR3","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1046\/j.1523-1755.2003.00932.x","volume":"63","author":"J Blacher","year":"2003","unstructured":"Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM . Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003; 63 (5): 1852\u20131860.","journal-title":"Kidney Int"},{"issue":"2","key":"BFjhh201556_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000045976","volume":"88","author":"G Coen","year":"2001","unstructured":"Coen G, Calabria S, Bellinghieri G, Pecchini F, Conte F, Chiappini MG et al. Parathyroidectomy in chronic renal failure: Short- and long-term results on parathyroid function, blood pressure and anemia. Nephron 2001; 88 (2): 149\u2013155.","journal-title":"Nephron"},{"issue":"6","key":"BFjhh201556_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0272-6386(96)90519-3","volume":"27","author":"DJA Goldsmith","year":"1996","unstructured":"Goldsmith DJA, Covic AA, Venning MC, Ackrill P . Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: Further evidence implicating calcium homeostasis in blood pressure regulation. Am J Kidney Dis 1996; 27 (6): 819\u2013825.","journal-title":"Am J Kidney Dis"},{"key":"BFjhh201556_CR6","unstructured":"United States Renal Data System. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2013. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, USA."},{"issue":"1","key":"BFjhh201556_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ki.2012.69","volume":"82","author":"PA Torres","year":"2012","unstructured":"Torres PA, De Broe M . Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease. Kidney Int 2012; 82 (1): 19\u201325.","journal-title":"Kidney Int"},{"issue":"3","key":"BFjhh201556_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.amjhyper.2004.10.019","volume":"18","author":"A Rybczynska","year":"2005","unstructured":"Rybczynska A, Boblewski K, Lehmann A, Orlewska C, Foks H, Drewnowska K et al. Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats. Am J Hypertens 2005; 18 (3): 364\u2013371.","journal-title":"Am J Hypertens"},{"issue":"3","key":"BFjhh201556_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1681\/ASN.2005090914","volume":"17","author":"T Odenwald","year":"2006","unstructured":"Odenwald T, Nakagawa K, Hadtstein C, Roesch F, Gohlke P, Ritz E et al. Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. J Am Soc Nephrol 2006; 17 (3): 655\u2013662.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"BFjhh201556_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5414\/CNP75181","volume":"75","author":"J Bonet","year":"2011","unstructured":"Bonet J, Bayes B, Fernandez-Crespo P, Casals M, Lopez-Ayerbe J, Romero R . Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism\u2014results of a small-scale, prospective, observational study. Clin Nephrol 2011; 75 (3): 181\u2013187.","journal-title":"Clin Nephrol"},{"issue":"4","key":"BFjhh201556_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","volume":"26","author":"P Raggi","year":"2011","unstructured":"Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2011; 26 (4): 1327\u20131339.","journal-title":"Nephrol Dial Transplant"},{"key":"BFjhh201556_CR12","first-page":"134","volume":"27","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Inoue T, Watanabe Y, Kikuta T, Sato T, Tsuda M et al. Does cinacalcet HCL, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism, improve arterial stiffness in patients on continuous ambulatory peritoneal dialysis? Adv Perit Dial 2011; 27: 134\u2013139.","journal-title":"Adv Perit Dial"},{"issue":"26","key":"BFjhh201556_CR13","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"GM Chertow","year":"2012","unstructured":"Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 2012; 367 (26): 2482\u20132494.","journal-title":"N Engl J Med"},{"issue":"5","key":"BFjhh201556_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2215\/CJN.04381206","volume":"2","author":"GM Chertow","year":"2007","unstructured":"Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J et al. Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and design overview. Clin J Am Soc Nephrol 2007; 2 (5): 898\u2013905.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFjhh201556_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical analysis with missing data","author":"RJ Little","year":"2002","unstructured":"Little RJ, RUBIN DB . Statistical analysis with missing data 2002. John Wiley & Sons, Inc.."},{"issue":"9349","key":"BFjhh201556_CR16","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins S . Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360 (9349): 1903\u20131913.","journal-title":"Lancet"},{"issue":"6","key":"BFjhh201556_CR17","first-page":"878","volume":"16","author":"KM Chow","year":"2003","unstructured":"Chow KM, Szeto CC, Kum LC, Kwan BC, Fung TM, Wong TY et al. Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. J Nephrol 2003; 16 (6): 878\u2013885.","journal-title":"J Nephrol"},{"issue":"8160","key":"BFjhh201556_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(80)90602-9","volume":"315","author":"T Dr\u00fceke","year":"1980","unstructured":"Dr\u00fceke T, Fleury J, Toure Y, de Vernejoul P, Fauchet M, Lesourd P et al. Effect of parathyroidectomy on left-ventricular function in h\u00e6modialysis patients. The Lancet 1980; 315 (8160): 112\u2013114.","journal-title":"The Lancet"},{"issue":"3","key":"BFjhh201556_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/j.ajkd.2005.04.035","volume":"46","author":"AJ Bleyer","year":"2005","unstructured":"Bleyer AJ, Burkart J, Piazza M, Russell G, Rohr M, Carr JJ . Changes in cardiovascular calcification after parathyroidectomy in patients with esrd. Am J Kidney Dis 2005; 46 (3): 464\u2013469.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"BFjhh201556_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000013301","volume":"18","author":"O Ifudu","year":"1998","unstructured":"Ifudu O, Matthew JJ, Macey LJ, Hong JS, Sumrani N, Sommer BG et al. Parathyroidectomy does not correct hypertension in patients on maintenance hemodialysis. Am J Nephrol 1998; 18 (1): 28\u201334.","journal-title":"Am J Nephrol"},{"issue":"2","key":"BFjhh201556_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000063291","volume":"92","author":"J Almirall","year":"2002","unstructured":"Almirall J, Lopez T, Comerma I, Garcia E, Marques G . Effect of parathyroidectomy on blood pressure in dialysis patients. Nephron 2002; 92 (2): 495\u2013496.","journal-title":"Nephron"},{"issue":"8","key":"BFjhh201556_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/TP.0b013e31822d87e8","volume":"92","author":"E Zitt","year":"2011","unstructured":"Zitt E, Woess E, Mayer G, Lhotta K . Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism. Transplantation 2011; 92 (8): 883\u2013889.","journal-title":"Transplantation"},{"issue":"2","key":"BFjhh201556_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/cvr\/cvt249","volume":"101","author":"L Henaut","year":"2014","unstructured":"Henaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A et al. Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action. Cardiovasc Res 2014; 101 (2): 256\u2013265.","journal-title":"Cardiovasc Res"},{"key":"BFjhh201556_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.phrs.2013.07.006","volume":"76","author":"P Martinez-Miguel","year":"2013","unstructured":"Martinez-Miguel P, Medrano-Andres D, Lopes-Martin V, Arribas-Gomez I, Rodriguez-Puyol M, Rodriguez-Puyol D et al. Regulation of endothelin-converting enzyme-1 (ECE-1) by the calcimimetic R-568. Pharmacol Res 2013; 76: 106\u2013118.","journal-title":"Pharmacol Res"},{"issue":"2","key":"BFjhh201556_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1523-1755.1998.00005.x","volume":"54","author":"PG Zager","year":"1998","unstructured":"Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D et al. \"U\" curve association of blood pressure and mortality in hemodialysis patients. Medical directors of dialysis clinic, inc. Kidney Int 1998; 54 (2): 561\u2013569.","journal-title":"Kidney Int"},{"issue":"4","key":"BFjhh201556_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1053\/j.ajkd.2006.07.005","volume":"48","author":"Z Li","year":"2006","unstructured":"Li Z, Lacson E Jr., Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM et al. The epidemiology o f systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48 (4): 606\u2013615.","journal-title":"Am J Kidney Dis"},{"key":"BFjhh201556_CR27","first-page":"S1","volume":"45","author":"National Kidney Foundation","year":"2005","unstructured":"National Kidney Foundation. Kdoqi clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45: S1\u2013S154.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"BFjhh201556_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1161\/HYPERTENSIONAHA.109.144899","volume":"55","author":"R Agarwal","year":"2010","unstructured":"Agarwal R . Blood pressure and mortality among hemodialysis patients. Hypertension 2010; 55 (3): 762\u2013768.","journal-title":"Hypertension"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201556","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T19:09:02Z","timestamp":1647544142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFjhh201556"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2015.56","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,4]]},"assertion":[{"value":"24 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Grant, consulting fee\/honorarium, speaking fees, stock options or travel support relevant to current manuscript: Abbott\/Abbvie: JF, CH, RC-R, DW; Affymax: CH; Amgen: SA, GB, GC, TD, JF, CH, GL, SM, PP, RC-R, DW (note: no honoraria were received for writing or reviewing the manuscript); Astra Zeneca: RC-R; Chugai Pharmaceutical Co: JF; ClearView Healthcare Partners: CH; CorMedix: CH; Danone: RC-R; Davita: GB; Eli Lilly: SM; Fibrogen: CH; Fresenius Medical Care: TD, JF, RC-R, DW; Genzyme\/Sanofi: GB, TD, JF, SM, RC-R, DW; Johnson & Johnson: CH, RC-R; KAI Pharmaceuticals: GB, SM; Keryx: GB, GC, CH; Medtronic: CH; Merck: DW, CH; Novartis: SM; Otsuka: DW; Pfizer: RC-R; Reata Pharmaceuticals: RC-R; Roche: RC-R; Satellite Healthcare: GC; Shire: JF, SM, DW; Vifor: JF, SM, DW; ZS Pharma: CH, DW. Employees and stock holders of Amgen: BD, WG. KM\u2019s financial disclosures before 1 August 2013, can be viewed at ExternalRef removed; disclosures after 1 August 2013, can be viewed at ExternalRef removed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}